Use of bacterium for manufacture of a vaccine

Details Use of bacterium for manufacture of a vaccine Use of bacterium for manufacture of a vaccine

2010-12-01

2011-12-27

Schultz, Doug (Department: 1633)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S829000, C424S820000

Reexamination Certificate

active

08084040

ABSTRACT:
The present invention relates to the use of live attenuated bacteria for the manufacture of a vaccine for submucosal administration.

REFERENCES:
patent: 4521513 (1985-06-01), Russell
patent: 5895654 (1999-04-01), Hartford et al.
patent: 5895756 (1999-04-01), Barrett et al.
patent: 5961985 (1999-10-01), Sprouse et al.
patent: 6120775 (2000-09-01), Jacobs
patent: 6344201 (2002-02-01), Maurelli et al.
patent: 6682745 (2004-01-01), Jacobs et al.
patent: 0756518 (1998-06-01), None
patent: 0894500 (2004-06-01), None
patent: 2033233 (1980-05-01), None
Curtiss III et al, “Strategies fo rthe Use of Live Recombinant Avirulent Bacterial Vaccines for Mucosal Immunication”, Academic Press, pp. 499-511 (1996).
Curtiss, “Bacterial Infectious Disease Control by Vaccine Development”, J. Clin. Invest., vol. 110, No. 8, pp. 1061-1066 (2002).
Detmer et al, “Live Bacterial Vaccines—A Review and Identification of Potential Hazards”, Microb Cell Fact., vol. 23, No. 5, pp. 1-12 (2006).
Forrest, “Indirect Measurement of intestinal Immune Response to an Orally Administered Attenuated Bacterial Vaccine”, Infect. Immun., vol. 60, No. 5, pp. 2023-2029 (1992).
Frey, “Biological Safety Concepts of Genetically Modified Live Bacterial Vaccines”, Vaccine, vol. 25, pp. 5598-5605 (2007).
Galen et al, “Can a ‘Flawless’ Live Vector Vaccine Strain Be Engineered?”, Trends in Microbiology, vol. 9, No. 8, pp. 372-376 (2001).
Haralambiev, “The Immunology Response of Calves After Submucosal Application of a Live Vaccine Against Parainfluenza-3- and Adenovirus”, Archiv fur Experimentelle Veterinarmedizin, vol. 29, No. 3, pp. 397-400 (1975).
Lohman et al, “Mucosal Immunization with a Live, Virulence-Attenuated Simian Immunodeficiency Virus (SIV) Vaccine Elicits Antiviral Cytotoxic T Lymphocytes and Antibodies in Rhesus Macaques”, Journal of Medical Primatology, vol. 23, pp. 95-101 (1994).
Medina et al, “Use of Live Bacterial Vaccine Vectors for Antigen Delivery: Potential and Limitations”, Vaccine, vol. 19, pp. 1573-1580 (2001).
Slater, “Immunological Control of Viral and Bacterial Pathogens”, AAEP Proceedings, vol. 46, pp. 10-20 (2000).
Titball et al, “Vaccination Against Bubonic and Pneumonic Plague”, Vaccine, vol. 19, pp. 4175-4184 (2001).
Walker, “Antibody Responses of Monkeys to Oral and Local Immunization withStreptococcus mutans”, Infection and Immunity, vol. 31, No. 1, pp. 61-70 (1981).

Affiliated with

Also associated with

Rating

Use of bacterium for manufacture of a vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bacterium for manufacture of a vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bacterium for manufacture of a vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4315800